Vitrolife AB (publ) (VITR.ST)
SEK 214.4
(1.13%)
SEK 214.4
(1.13%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.87 Billion SEK | -8.22% |
| 2022 | 2.04 Billion SEK | 0.8% |
| 2021 | 2.02 Billion SEK | 4052.47% |
| 2020 | 48.81 Million SEK | -20.26% |
| 2019 | 61.21 Million SEK | 0.0% |
| 2018 | - SEK | -100.0% |
| 2017 | 399 Thousand SEK | -14.38% |
| 2016 | 466 Thousand SEK | -98.69% |
| 2015 | 35.62 Million SEK | -40.64% |
| 2014 | 60.01 Million SEK | 177.58% |
| 2013 | 21.62 Million SEK | -62.87% |
| 2012 | 58.22 Million SEK | -5.39% |
| 2011 | 61.54 Million SEK | 93.71% |
| 2010 | 31.77 Million SEK | 341.69% |
| 2009 | 7.19 Million SEK | 116.59% |
| 2008 | 3.32 Million SEK | 0.0% |
| 2007 | - SEK | 0.0% |
| 2006 | - SEK | 0.0% |
| 2005 | - SEK | 0.0% |
| 2004 | - SEK | 0.0% |
| 2003 | - SEK | 0.0% |
| 2002 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.89 Billion SEK | 0.85% |
| 2024 Q3 | 1.8 Billion SEK | -3.47% |
| 2024 Q2 | 1.87 Billion SEK | -1.0% |
| 2023 FY | 1.87 Billion SEK | -8.22% |
| 2023 Q4 | 1.87 Billion SEK | -6.76% |
| 2023 Q3 | 2.01 Billion SEK | -5.36% |
| 2023 Q2 | 2.12 Billion SEK | 5.88% |
| 2023 Q1 | 2 Billion SEK | -1.76% |
| 2022 Q1 | 1.98 Billion SEK | -2.16% |
| 2022 Q4 | 2.04 Billion SEK | 1.69% |
| 2022 FY | 2.04 Billion SEK | 0.8% |
| 2022 Q3 | 2 Billion SEK | -1.42% |
| 2022 Q2 | 2.03 Billion SEK | 2.77% |
| 2021 Q2 | 55.88 Million SEK | 19.55% |
| 2021 FY | 2.02 Billion SEK | 4052.47% |
| 2021 Q1 | 46.74 Million SEK | -4.23% |
| 2021 Q4 | 2.02 Billion SEK | 3752.61% |
| 2021 Q3 | 52.6 Million SEK | -5.85% |
| 2020 Q1 | 59.28 Million SEK | -3.15% |
| 2020 Q4 | 48.81 Million SEK | -6.46% |
| 2020 FY | 48.81 Million SEK | -20.26% |
| 2020 Q2 | 55.89 Million SEK | -5.73% |
| 2020 Q3 | 52.18 Million SEK | -6.64% |
| 2019 Q2 | 66.18 Million SEK | -0.02% |
| 2019 Q1 | 66.19 Million SEK | 0.0% |
| 2019 FY | 61.21 Million SEK | 0.0% |
| 2019 Q4 | 61.21 Million SEK | -4.86% |
| 2019 Q3 | 64.33 Million SEK | -2.79% |
| 2018 Q1 | 396 Thousand SEK | -0.75% |
| 2018 Q2 | - SEK | -100.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q4 | - SEK | 0.0% |
| 2018 FY | - SEK | -100.0% |
| 2017 FY | 399 Thousand SEK | -14.38% |
| 2017 Q4 | 399 Thousand SEK | -1.97% |
| 2017 Q3 | 407 Thousand SEK | -5.79% |
| 2017 Q2 | 432 Thousand SEK | -3.14% |
| 2017 Q1 | 446 Thousand SEK | -4.29% |
| 2016 Q1 | 33 Million SEK | -7.36% |
| 2016 Q4 | 466 Thousand SEK | -98.37% |
| 2016 Q3 | 28.66 Million SEK | -7.84% |
| 2016 Q2 | 31.1 Million SEK | -5.77% |
| 2016 FY | 466 Thousand SEK | -98.69% |
| 2015 Q1 | 53.63 Million SEK | -10.64% |
| 2015 Q4 | 35.62 Million SEK | -10.41% |
| 2015 Q3 | 39.76 Million SEK | -18.6% |
| 2015 Q2 | 48.85 Million SEK | -8.91% |
| 2015 FY | 35.62 Million SEK | -40.64% |
| 2014 Q3 | 11.01 Million SEK | -20.92% |
| 2014 Q4 | 60.01 Million SEK | 444.74% |
| 2014 Q2 | 13.93 Million SEK | -20.78% |
| 2014 Q1 | 17.58 Million SEK | -18.66% |
| 2014 FY | 60.01 Million SEK | 177.58% |
| 2013 Q4 | 21.62 Million SEK | -29.34% |
| 2013 Q2 | 47.86 Million SEK | -3.27% |
| 2013 Q1 | 49.47 Million SEK | -15.03% |
| 2013 Q3 | 30.59 Million SEK | -36.07% |
| 2013 FY | 21.62 Million SEK | -62.87% |
| 2012 Q1 | 52.76 Million SEK | -14.27% |
| 2012 Q4 | 58.22 Million SEK | 18.28% |
| 2012 FY | 58.22 Million SEK | -5.39% |
| 2012 Q2 | 53.95 Million SEK | 2.26% |
| 2012 Q3 | 49.23 Million SEK | -8.75% |
| 2011 Q3 | 29.26 Million SEK | 1.0% |
| 2011 Q1 | 32.49 Million SEK | 2.28% |
| 2011 Q2 | 28.97 Million SEK | -10.82% |
| 2011 FY | 61.54 Million SEK | 93.71% |
| 2011 Q4 | 61.54 Million SEK | 110.28% |
| 2010 FY | 31.77 Million SEK | 341.69% |
| 2010 Q4 | 31.77 Million SEK | 1071.93% |
| 2010 Q3 | 2.71 Million SEK | -17.65% |
| 2010 Q2 | 3.29 Million SEK | 0.0% |
| 2009 Q4 | 7.19 Million SEK | 0.0% |
| 2009 FY | 7.19 Million SEK | 116.59% |
| 2008 FY | 3.32 Million SEK | 0.0% |
| 2007 FY | - SEK | 0.0% |
| 2006 FY | - SEK | 0.0% |
| 2005 FY | - SEK | 0.0% |
| 2004 FY | - SEK | 0.0% |
| 2003 FY | - SEK | 0.0% |
| 2002 FY | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | -28.707% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | -28.707% |
| Arcoma AB | 1.92 Million SEK | -97201.505% |
| Bactiguard Holding AB (publ) | 42.3 Million SEK | -4331.995% |
| BICO Group AB (publ) | 1.75 Billion SEK | -6.813% |
| Boule Diagnostics AB (publ) | 57.7 Million SEK | -3149.567% |
| CellaVision AB (publ) | 28.66 Million SEK | -6441.306% |
| Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -840707.175% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.75 Million SEK | -106859.498% |
| Duearity AB (publ) | 2.94 Million SEK | -63675.51% |
| Dignitana AB (publ) | 6.07 Million SEK | -30754.04% |
| Episurf Medical AB (publ) | 2.3 Million SEK | -81421.739% |
| Getinge AB (publ) | 3.9 Billion SEK | 51.96% |
| Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | -29413.987% |
| Iconovo AB (publ) | 4.9 Million SEK | -38111.514% |
| Integrum AB (publ) | 4.84 Million SEK | -38603.269% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -909988.145% |
| Mentice AB (publ) | 2.14 Million SEK | -87353.358% |
| OssDsign AB (publ) | 214 Thousand SEK | -876068.224% |
| Paxman AB (publ) | 2.53 Million SEK | -73952.133% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 3 Million SEK | -62316.778% |
| SciBase Holding AB (publ) | 4.17 Million SEK | -44767.193% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 19.2 Million SEK | -9663.591% |
| Sedana Medical AB (publ) | 1.01 Million SEK | -185176.68% |
| Senzime AB (publ) | 8.57 Million SEK | -21758.242% |
| SpectraCure AB (publ) | 4.39 Million SEK | -42542.711% |
| Stille AB | 38.06 Million SEK | -4825.655% |
| Xvivo Perfusion AB (publ) | 21.16 Million SEK | -8757.291% |